Clinical trial
Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults
NCT01491607 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults
- Lead sponsor
- Emergent BioSolutions
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- May 31, 2012
- Enrollment
- 200 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.